Differentiation and reversal of malignant changes in colon cancer through PPARγ
Nature Medicine1998Vol. 4(9), pp. 1046–1052
Citations Over TimeTop 1% of 1998 papers
Pasha Sarraf, Elisabetta Mueller, Daniel M. Jones, Frederick J. King, Daniel J. DeAngelo, Jeffrey B. Partridge, Sylvia A. Holden, Lan Bo Chen, Samuel Singer, Christopher D.�M. Fletcher, Bruce M. Spiegelman
Related Papers
- → Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Functions Independently of PPARγ(2005)216 cited
- → Unique Ability of Troglitazone to Up-Regulate Peroxisome Proliferator-Activated Receptor-γ Expression in Hepatocytes(2002)62 cited
- → Troglitazone Induces Expression of PPARγ in Liver(1999)31 cited
- → Peroxisome proliferator‐activated receptor γ‐dependent and ‐independent growth inhibition of gastrointestinal tumour cells(2004)30 cited
- → Peroxisome Proliferator-Activated Receptor Gamma (PPAR-Γ) Agonist Troglitazone Suppresses Collagen Synthesis via Expression of the Downstream Target Mirnas: A Novel Strategy to Treat Skin Fibrosis?(2016)